Digital strength training for midlife women on GLP-1 meds
Part of Hormones & metabolism clinical trials.
This study looks at whether a guided strength-training app can help women in their 40s and 50s who are starting a GLP-1 medication (like Ozempic or Wegovy) build muscle and stay healthy. You'd follow a home-based workout plan for 12 weeks and attend a few in-person visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 40 and 54 years old.
- You started a GLP-1 medicine (like Ozempic, Wegovy, etc.) within the last 6 months.
- Your body mass index (BMI) is 27 or higher.
- You haven't been doing regular strength training in the past month.
- You can stand, sit, and move on your own without help.
- You have a smartphone (iPhone or Android) and are willing to use the study app.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is an online survey to understand how people taking GLP-1 medications (like Ozempic or Wegovy) are doing with resistance training. If you're an adult on a stable dose of a GLP-1 med for weight or diabetes, your input can help shape better exercise advice.
This study tests whether a 12-week program of exercise and personalized nutrition counseling can help obese adults maintain muscle and bone while taking GLP-1 medications (drugs that help with weight loss). GLP-1 drugs can sometimes cause muscle loss, so this trial explores whether targeted exercise and nutrition can prevent that.
This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.
This study tests a 6-month behavioral program (including exercise, diet, and mindfulness) designed to help you keep weight off after stopping GLP-1 or similar weight-loss medications. It's for people who have already lost at least 15% of their body weight and stopped or are stopping these medications.
This study looks at how GLP-1 medications (like Ozempic or Wegovy) combined with behavioral coaching through Noom affect weight loss and metabolic health over 12 months. You may qualify if you're interested in weight loss and willing to commit to a program for a year.
This study looks at using digital tools like apps to help manage weight. It's for people in a specialized weight management program in South East London.
Hear when a new Women Health trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.